Gefitinib vs Yttrium Y 90 Ibritumomab Tiuxetan

## Gefitinib vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview

This comparison examines the pharmacological differences between **Gefitinib** and **Yttrium Y 90 Ibritumomab Tiuxetan**.

## Mechanism of Action

**Gefitinib**: Selective reversible inhibitor of EGFR tyrosine kinase.

## Pharmacokinetics

**Half-life**: Gefitinib — 48 hours; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

## Chemical Properties

**Molecular Formula**: Gefitinib — C22H24ClFN4O3; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

**Molecular Weight**: Gefitinib — 446.9000 g/mol; Yttrium Y 90 Ibritumomab Tiuxetan — N/A.

**Type**: Gefitinib — Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.